{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:18:31Z","timestamp":1791224311456,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/rlu.0b013e31824c5dd0","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T10:35:44Z","timestamp":1342002944000},"page":"e196-e203","source":"Crossref","is-referenced-by-count":40,"title":["Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head"],"prefix":"10.1097","volume":"37","author":[{"given":"Koen","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamphrey","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Deblaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre Okito","family":"Kalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Van den Broecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Slaets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20210204","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2214\/AJR.07.2083","article-title":". Benign nonphysiologic lesions with increased 18F-FDG uptake on PETCT: characterization and incidence.","volume":"189","author":"Metser","year":"2007","journal-title":"Am J Roentgenol"},{"key":"R2-33-20210204","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00259-010-1496-z","article-title":". PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.","volume":"37","author":"Mertens","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-33-20210204","first-page":"4630","article-title":". Immortalization and transformation are associated with specific alterations in choline metabolism.","volume":"56","author":"Bhakoo","year":"1996","journal-title":"Cancer Res"},{"key":"R4-33-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1349-7006.1999.tb00764.x","article-title":". Increased choline kinase activity and elevated phosphocholine levels in human colon cancer.","volume":"90","author":"Nakagami","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"R5-33-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MNM.0b013e328330adc5","article-title":". 18F-choline PETCT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.","volume":"31","author":"Schillaci","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R6-33-20210204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.281.5378.794","article-title":"Choline, a vital amine.","volume":"281","author":"Blusztajn","year":"1998","journal-title":"Science"},{"key":"R7-33-20210204","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00259-010-1508-z","article-title":". Reduced dimethylaminoethanol in F-18 fluorofluoromethylcholine: an important step toward enhanced tumour visualization.","volume":"37","author":"Slaets","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-33-20210204","first-page":"110","article-title":". Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.","volume":"61","author":"DeGrado","year":"2001","journal-title":"Cancer Res"},{"key":"R9-33-20210204","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/jns.2003.99.3.0474","article-title":". Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.","volume":"99","author":"Hara","year":"2003","journal-title":"J Neurosurg"},{"key":"R10-33-20210204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1148\/radiol.2442060898","article-title":". Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.","volume":"244","author":"Kwee","year":"2007","journal-title":"Radiology"},{"key":"R11-33-20210204","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1471-4159.2001.00093.x","article-title":"Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.","volume":"76","author":"Allen","year":"2001","journal-title":"J Neurochem"},{"key":"R12-33-20210204","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clineuro.2010.09.012","article-title":". Promising role of 18F fluorocholine PETCT vs 18F fluorodeoxyglucose PETCT in primary brain tumoursearly experience.","volume":"113","author":"Lam","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"R13-33-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1552-6569.2004.tb00253.x","article-title":". Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumour evaluation.","volume":"14","author":"Kwee","year":"2004","journal-title":"J Neuroimaging"},{"key":"R14-33-20210204","first-page":"1931","article-title":". Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumour recurrence.","volume":"45","author":"Spaeth","year":"2004","journal-title":"J Nucl Med"},{"key":"R15-33-20210204","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.202.2.9015080","article-title":". Brain tumours: detection with C-11 choline PET.","volume":"202","author":"Shinoura","year":"1997","journal-title":"Radiology"},{"key":"R16-33-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0b013e31818f4369","article-title":". C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience.","volume":"34","author":"Giovacchini","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R17-33-20210204","first-page":"417","article-title":". Incidental detection by 11Ccholine PETCT of meningiomas in prostate cancer patients.","volume":"53","author":"Fallanca","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R18-33-20210204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2006.02.047","article-title":". 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.","volume":"66","author":"Grosu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-33-20210204","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2008.02.058","article-title":". Effect of 11C-methionine-positron emission tomography on gross tumour volume delineation in stereotactic radiotherapy of skull base meningiomas.","volume":"72","author":"Astner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-33-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","article-title":". Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and 68Ga-DOTATOC-PET.","volume":"65","author":"Milker-Zabel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-33-20210204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-4-56","article-title":". 68Ga-DOTATOC-PETCT for meningioma IMRT treatment planning.","volume":"4","author":"Gehler","year":"2009","journal-title":"Radiat Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e31824c5dd0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:26:06Z","timestamp":1621884366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201208000-00033"}},"subtitle":["A PET\/MRI Evaluation"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31824c5dd0","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}